A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection

Béla Dénes, Ryan N. Fuller, Wayne Kelin, Tessa R. Levin, Jaipuneet Gil, Aaren Harewood, Márta Lőrincz, Nathan R. Wall, Anthony F. Firek, William H.R. Langridge

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number1865
JournalVaccines
Volume11
Issue number12
DOIs
StatePublished - Dec 2023

ASJC Scopus Subject Areas

  • Immunology
  • Pharmacology
  • Drug Discovery
  • Infectious Diseases
  • Pharmacology (medical)

Keywords

  • COVID-19
  • SARS-CoV-2
  • angiotensin converting enzyme (ACE-2) receptor binding domain (RBD)
  • beta coronaviruses
  • cholera toxin B subunit
  • mucosal immunization
  • protein subunit vaccine
  • sIgA
  • virus neutralization

Cite this